Geriatric Oncology

Top Story

Autologous HSCT effective, safe for older patients with multiple myeloma

Autologous HSCT effective, safe for older patients with multiple myeloma
December 7, 2019
Meeting NewsPerspective

Genetic alterations at diagnosis predict transplant outcomes for older patients with AML

December 7, 2019
ORLANDO — Genetic alterations at diagnosis predicted OS and leukemia-free survival for older individuals with acute myeloid leukemia who underwent allogeneic…

Partnership funds research to assess connection between cancer, aging

December 2, 2019
The Partnership for Aging and Cancer Research Program awarded seven grants intended to fund research into the link between aging and cancer. The partnership — a…
In the JournalsPerspective

CDK 4/6 inhibitors effective across age groups in breast cancer subset

November 22, 2019
Combinations of cyclin-dependent kinase 4/6 inhibitors and aromatase inhibitors appeared effective among older and younger women with hormone receptor-positive…
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

More »
Video
Meeting News Coverage

VIDEO: Liquid biopsy technology a ‘major advance’ but still requires validation

May 5, 2016
More »